APA (7th ed.) Citation

Mahmoud Ghannoum, Maiken Cavling Arendrup, Vishnu P. Chaturvedi, Shawn R. Lockhart, Thomas S. McCormick, Sudha Chaturvedi, . . . Thomas J. Walsh. (2020). Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of <i>Candida auris</i> Infections. MDPI AG.

Chicago Style (17th ed.) Citation

Mahmoud Ghannoum, et al. Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of <i>Candida Auris</i> Infections. MDPI AG, 2020.

MLA (9th ed.) Citation

Mahmoud Ghannoum, et al. Ibrexafungerp: A Novel Oral Triterpenoid Antifungal in Development for the Treatment of <i>Candida Auris</i> Infections. MDPI AG, 2020.